Ursula Pertl

1.0k total citations
14 papers, 808 citations indexed

About

Ursula Pertl is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ursula Pertl has authored 14 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Ursula Pertl's work include Immunotherapy and Immune Responses (9 papers), Virus-based gene therapy research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Ursula Pertl is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Virus-based gene therapy research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Ursula Pertl collaborates with scholars based in United States, Germany and Austria. Ursula Pertl's co-authors include Ralph A. Reisfeld, Holger N. Lode, Andreas G. Niethammer, Rong Xiang, Harald Wodrich, Brian P. Eliceiri, Jürgen C. Becker, Stephen D. Gillies, Gerhard Gaedicke and J M Ruehlmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Ursula Pertl

14 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ursula Pertl United States	11	403	374	288	138	115	14	808
Barry Kobrin United States	10	441 1.1×	278 0.7×	442 1.5×	104 0.8×	74 0.6×	18	816
Peer Papior Germany	7	294 0.7×	609 1.6×	412 1.4×	39 0.3×	140 1.2×	7	1.2k
Patricia Álamo Spain	22	295 0.7×	610 1.6×	245 0.9×	131 0.9×	59 0.5×	43	1.0k
Kostas Kosmatopoulos France	16	715 1.8×	494 1.3×	302 1.0×	116 0.8×	76 0.7×	25	948
John Copier United Kingdom	15	449 1.1×	379 1.0×	270 0.9×	43 0.3×	60 0.5×	29	902
Françoise Quintin‐Colonna France	13	569 1.4×	216 0.6×	362 1.3×	202 1.5×	106 0.9×	19	905
Wayne Aldrich United States	19	590 1.5×	501 1.3×	419 1.5×	42 0.3×	262 2.3×	46	1.1k
Cornelia Marty Switzerland	12	465 1.2×	825 2.2×	284 1.0×	32 0.2×	132 1.1×	12	1.3k
Kathy Mulgrew United States	11	280 0.7×	412 1.1×	557 1.9×	42 0.3×	268 2.3×	24	980
Wolfgang Ebel United States	9	97 0.2×	285 0.8×	190 0.7×	79 0.6×	144 1.3×	11	675

Countries citing papers authored by Ursula Pertl

Since Specialization

Citations

This map shows the geographic impact of Ursula Pertl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Pertl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Pertl more than expected).

Fields of papers citing papers by Ursula Pertl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Pertl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Pertl. The network helps show where Ursula Pertl may publish in the future.

Co-authorship network of co-authors of Ursula Pertl

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Pertl. A scholar is included among the top collaborators of Ursula Pertl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Pertl. Ursula Pertl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Niethammer, Andreas G., Rong Xiang, Jürgen C. Becker, et al.. (2002). A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nature Medicine. 8(12). 1369–1375. 310 indexed citations

2.

Pertl, Ursula, Harald Wodrich, J M Ruehlmann, et al.. (2002). Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood. 101(2). 649–654. 32 indexed citations

3.

Niethammer, Andreas G., Rong Xiang, Jürgen Becker, et al.. (2002). A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nature Medicine. 8(12). 1369–1375. 36 indexed citations

4.

Ruehlmann, J M, Andreas G. Niethammer, Yi Ba, et al.. (2001). MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する. Cancer Research. 61(23). 8498–8503. 1 indexed citations

5.

Pertl, Ursula, Andrew D. Luster, Nissi Varki, et al.. (2001). IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy. The Journal of Immunology. 166(11). 6944–6951. 94 indexed citations

6.

Ruehlmann, J M, Rong Xiang, Andreas G. Niethammer, et al.. (2001). MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.. PubMed. 61(23). 8498–503. 50 indexed citations

7.

Xiang, Rong, Steve Silletti, Holger N. Lode, et al.. (2001). Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.. PubMed. 7(3 Suppl). 856s–864s. 44 indexed citations

8.

Shabat, Doron, Holger N. Lode, Ursula Pertl, et al.. (2001). In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proceedings of the National Academy of Sciences. 98(13). 7528–7533. 80 indexed citations

9.

Lode, Holger N., Rong Xiang, Patrizia Perri, et al.. (2000). What to do with targeted IL-2. Drugs of today. 36(5). 321–321. 4 indexed citations

10.

Lode, Holger N., Rong Xiang, Ursula Pertl, et al.. (2000). Melanoma immunotherapy by targeted IL-2 depends on CD4+ T-cell help mediated by CD40/CD40L interaction. Journal of Clinical Investigation. 105(11). 1623–1630. 31 indexed citations

11.

Lode, Holger N., Ursula Pertl, Rong Xiang, Gerhard Gaedicke, & R. Reisfeld. (2000). Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma. Medical and Pediatric Oncology. 35(6). 641–646. 31 indexed citations

12.

Balicki, Danuta, Ralph A. Reisfeld, Ursula Pertl, Ernest Beutler, & Holger N. Lode. (2000). Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proceedings of the National Academy of Sciences. 97(21). 11500–11504. 50 indexed citations

13.

Klingebiel, Thomas, Ursula Pertl, Clemens F. Hess, et al.. (1998). Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial. Medical and Pediatric Oncology. 30(5). 269–275. 42 indexed citations

14.

Klingebiel, Thomas, Ursula Pertl, Clemens F. Hess, et al.. (1998). Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 Trial. Medical and Pediatric Oncology. 30(5). 269–275. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact